Latest / Cleveland Clinic Cancer Advances
Biomarkers Predict Outcomes of CAR T-Cell Therapy in Patients with Diffuse Large B-Cell Lymphoma
Brian Hill, MD, PhD, Director of the Lymphoid Malignancies Program joins the Cancer Advances podcast to discuss research and findings that were presented at the 2021 American Society of Hematology Annual Meeting (ASH). Listen as Dr. Hill discusses how CAR T-Cell therapy may be a lifesaving option for patients with relapsed or refractory disease.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.